Clinical Trials in Voronezh, Russia
11 recruiting
Showing 1–11 of 11 trials
Recruiting
Clinical& Demographic Profiles of patIents With unControllEd Asthma in Russia: Multi-center oBsErvational ReGistry Study
Uncontrolled Asthma
AstraZeneca9,000 enrolled47 locationsNCT06521229
Recruiting
Non-interventional Study to Assess the Effectiveness and Safety of Ribociclib in the Adjuvant Therapy of Hormone Receptor Positive (HR+) HER2-negative Stage II and III Breast Cancer in Real Clinical Practice in Russia
Breast Cancer
Novartis Pharmaceuticals2,766 enrolled37 locationsNCT06930859
Recruiting
Phase 2
Pharmacokinetics, Efficacy and Safety of Olokizumab In Patients With Juvenile Idiopathic Arthritis
Juvenile Idiopathic Arthritis
R-Pharm International, LLC71 enrolled14 locationsNCT07517575
Recruiting
Clinical and demOgRaphic Features of Patients With Uncontrolled Severe Asthma in Russia (CORSAR)
Severe Asthma
AstraZeneca5,000 enrolled37 locationsNCT06472310
Recruiting
Study of Patient With Frequent COPD Exacerbations
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca2,000 enrolled6 locationsNCT07221981
Recruiting
Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in Russia
Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals2,382 enrolled20 locationsNCT06858332
Recruiting
Left Ventricular Reverse Remodeling Evaluation After Surgical Correction of Aortic Regurgitation
Diastolic Heart FailureAortic Valve RegurgitationMitral Valve Regurgitation+3 more
Petrovsky National Research Centre of Surgery120 enrolled2 locationsNCT06805253
Recruiting
PRospectIve ObseRvatIonal mulTicenter Study of Patients With Arterial hYpertension and CKD in the Population of Russia
Arterial Hypertension, Chronic Kidney Disease
AstraZeneca10,000 enrolled30 locationsNCT06372431
Recruiting
Observational Study of Efficiency of Cytoflavin, in Patients With Ischemic Stroke Not Receiving Reperfusion Therapy
Stroke, IschemicStroke, Acute
POLYSAN Scientific & Technological Pharmaceutical Company562 enrolled17 locationsNCT06514976
Recruiting
Phase 2Phase 3
Efficacy and Safety of Olokizumab in Patients With Progressive Fibrosing Interstitial Lung Diseases
Lung Diseases, Interstitial
R-Pharm International, LLC138 enrolled33 locationsNCT06440746
Recruiting
Not Applicable
Mast Cells and Its Proteases in COPD
COPD Exacerbation
Voronezh N.N. Burdenko State Medical Academy30 enrolled1 locationNCT06392334